Related Experiment Video
Updated: Jun 13, 2026
Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Long-term follow up of very low-dose LINAC based stereotactic radiotherapy in temporal lobe epilepsy
Shuli Liang1, Tianxing Liu, Anmin Li
1Neurosurgery Department, First Affiliated Hospital of General Hospital of PLA, No. 51, Fucheng Road, Beijing 100048, China. liangsl@dx304.com
Objective:
Several prospective multicenter studies have demonstrated high safety efficacy for mesial temporal lobe epilepsy (TLE) with Gamma Knife radiosurgery using 24 Gy at the margin. In this paper we reported the long-term outcome of 7 patients with TLE treated with very low-dose linear accelerator (LINAC) based fractionated stereotactic radiotherapy (FSRT). We also discussed the feasibility of LINAC for TLE.
Methods:
To record the treatment process, outcomes and side effects for 7 patients with TLE treated with low-dose LINAC, whose marginal dose of all cases was 12 Gy at the 85% isodose line, and post-FSRT seizure frequencies were compared with those of patients pre-FSRT. One special case (case 6) was reported in detail.
Results:
Reduction of seizure frequency post-FSRT was 50% in 2 cases, 30% in 1 case, and 0% in 2 cases, and seizure frequency increased more than 100% in 2 cases. No patient was seizure free at the last follow up. 2 cases presented transitory complications and 2 cases showed an obvious drop in IQ, memory decline and permanent neurologic complications, including partial aphasia and mild hemiplegia in 1 case, progressive ataxia and cognition decline in another case.
Conclusion:
Outcome of TLE treated by very low-dose LINAC based FSRT was poor because of mild reduction in seizure attack frequency and serious complications.
